{
    "2019-02-25": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Technician says it's time to fade the biotech rally",
                "features": {
                    "keywords": [
                        "biotech",
                        "rally",
                        "fade"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Pharma CEOs to face tough questions about skyrocketing drug prices",
                "features": {
                    "keywords": [
                        "Pharma",
                        "CEOs",
                        "drug prices",
                        "skyrocketing"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Factbox: Pharma company executives to testify at U.S. Senate drug price hearing",
                "features": {
                    "keywords": [
                        "Pharma",
                        "executives",
                        "testify",
                        "Senate",
                        "drug price hearing"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "There will be continued interest in gene therapy, says biotech analyst",
                "features": {
                    "keywords": [
                        "gene therapy",
                        "interest",
                        "biotech"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-07",
                "original_text": "Drug pricing showdown: Pharma CEOs set to testify before Congress on Capitol Hill Tuesday",
                "features": {
                    "keywords": [
                        "drug pricing",
                        "Pharma",
                        "CEOs",
                        "Congress",
                        "Capitol Hill"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-08",
                "original_text": "Big Pharma to testify in Senate drug pricing hearing",
                "features": {
                    "keywords": [
                        "Big Pharma",
                        "testify",
                        "Senate",
                        "drug pricing"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-09",
                "original_text": "The Zacks Analyst Blog Highlights: Walmart, Pfizer, Eli Lilly, Merck and Microsoft",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst",
                        "Blog",
                        "Walmart",
                        "Pfizer",
                        "Eli Lilly",
                        "Merck",
                        "Microsoft"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "retail",
                        "technology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-10",
                "original_text": "Dowâ€™s Best-Performing Stock in 2018 Gets Vote of Confidence",
                "features": {
                    "keywords": [
                        "Dow",
                        "Best-Performing",
                        "Stock",
                        "Vote",
                        "Confidence"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-11",
                "original_text": "Healthcare Stocks Leading the Sector",
                "features": {
                    "keywords": [
                        "Healthcare",
                        "Stocks",
                        "Leading",
                        "Sector"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-12",
                "original_text": "What's in the Cards for Nektar (NKTR) This Earnings Season?",
                "features": {
                    "keywords": [
                        "Nektar",
                        "Earnings",
                        "Season"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}